| 9.1 -0.11 (-1.19%) | 06-15 09:38 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | ||||
| Targets | 6-month : | 10.79 |
1-year : | 12.6 |
| Resists | First : | 9.23 |
Second : | 10.79 |
| Pivot price | 9.06 |
|||
| Supports | First : | 9 |
Second : | 8.85 |
| MAs | MA(5) : | 9.15 |
MA(20) : | 9.03 |
| MA(100) : | 9.25 |
MA(250) : | 9.11 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 90.5 |
D(3) : | 87.8 |
| RSI | RSI(14): 61.4 |
|||
| 52-week | High : | 9.86 | Low : | 8.45 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ GRX ] has closed below upper band by 7.7%. Bollinger Bands are 3.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 9.25 - 9.29 | 9.29 - 9.32 |
| Low: | 9.07 - 9.12 | 9.12 - 9.16 |
| Close: | 9.14 - 9.21 | 9.21 - 9.27 |
The Gabelli Healthcare & Wellness Trust operates as a closed-ended equity fund, originally established by GAMCO Investors, Inc. Gabelli Funds, LLC serves as its investment manager. This fund's mandate is to invest globally in public equities, with a predominant focus on companies operating within the healthcare and wellness sectors. It considers businesses irrespective of their market capitalization, investing across the full spectrum. To gauge its performance, the Trust benchmarks its portfolio against the S&P 500 Index, the S&P 500 Consumer Staples Index, and the S&P 500 Health Care Index. Formed on February 20, 2007, The Gabelli Healthcare & Wellness Trust is domiciled in the United States.
Wed, 27 May 2026
Gabelli Healthcare & WellnessRx Trust Announces $0.17 Per Share Distribution for Second Quarter, Payable June 24, 2026 - geneonline.com
Sat, 23 May 2026
EBITDA per share of The Gabelli Healthcare & Wellness Trust – NYSE:GRX - TradingView
Wed, 13 May 2026
Gabelli Healthcare & WellnessRx Trust Declares Second Quarter Distribution of $0.17 Per Share - GlobeNewswire
Sat, 25 Apr 2026
Healthcare CEF Insiders Are Quietly Buying While 60% of Distributions Return Capital - 24/7 Wall St.
Fri, 17 Apr 2026
GRX’s 14-Year Dividend Streak Holds Firm as Rate Cuts Ease Leverage Costs - 24/7 Wall St.
Wed, 10 Dec 2025
Gabelli Healthcare & WellnessRx Trust To Go Ex-Dividend On December 12th, 2025 With 0.17 USD Dividend Per Share - Moomoo
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 15 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 1.7 (%) |
| Held by Institutions | 40.9 (%) |
| Shares Short | 7 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0.15 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 61.39 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0.17 |
| Forward Dividend | 0 |
| Dividend Yield | 1.8% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |